awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44041367-AF86307A-C7E0-4000-A5A0-24B447BCB8ED
Q44041367-AF86307A-C7E0-4000-A5A0-24B447BCB8ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44041367-AF86307A-C7E0-4000-A5A0-24B447BCB8ED
A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia.
P2860
Q44041367-AF86307A-C7E0-4000-A5A0-24B447BCB8ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44041367-AF86307A-C7E0-4000-A5A0-24B447BCB8ED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
abd22949560717db8d0d8ef7759cc653a3b48fe2
P2860
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-M